Oaktree Acquisition Corp. III Life Sciences (OACCU) Notes Payables (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Notes Payables came in at $11824.0 in Q1 2026, little changed YoY from $11824.0 in Q1 2025, and little changed on a QoQ basis from $11824.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Notes Payables (2024 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Notes Payables data on file, last reported at $11824.0 in Q1 2026.
- Quarterly Notes Payables changed 0.0% year-over-year to $11824.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11824.0 (changed 0.0% YoY) and the FY2025 annual result came in at $11824.0, changed 0.0% from the prior year.
- Notes Payables steadied at $11824.0 in Q1 2026, from $11824.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $11824.0 in Q4 2024 to a low of $11824.0 in Q4 2024.
- A 3-year average of $11824.0 and a median of $11824.0 in 2024 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 0.0% in 2025, down 0.0% in 2025.
- Tracing OACCU's Notes Payables over 3 years: stood at $11824.0 in 2024, then changed by 0.0% to $11824.0 in 2025, then changed by 0.0% to $11824.0 in 2026.
- The last three Notes Payables figures came in at $11824.0 (Q1 2026), $11824.0 (Q4 2025), and $11824.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,824.00 |
| Mar 31, 2026 | 11,824.00 |
| Dec 31, 2025 | 11,824.00 |
| Sep 30, 2025 | 11,824.00 |
| Jun 30, 2025 | 11,824.00 |
| Mar 31, 2025 | 11,824.00 |
| Dec 31, 2024 | 11,824.00 |